BDBM614764 2-(1-Cyclohexyl- 1H-pyrazol-4- yl)-5-[({1-[2- fluoro-4- (trifluoromethyl) phenyl]cyclo- propyl}carbonyl) amino]benzoic acid::US20230271931, Example 122

SMILES OC(=O)c1cc(NC(=O)C2(CC2)c2ccc(cc2F)C(F)(F)F)ccc1-c1cnn(c1)C1CCCCC1

InChI Key InChIKey=QLXDHHAUENNNDY-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 614764   

TargetB1 bradykinin receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM614764(US20230271931, Example 122 | 2-(1-Cyclohexyl- 1H-p...)
Affinity DataIC50: 13nMAssay Description:Notably, Compound Examples are tested in the FLIPR assays in the absence (hB1 free IC50) of 0.1% BSA in assay buffer, in order to assess the potency ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/15/2023
Entry Details
Go to US Patent